TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model

MLA

Alain Faivre-Chauvet, et al. “TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 MAb in a Syngeneic Multiple Myeloma Model.” Bioconjugate Chemistry, vol. 30, Aug. 2019, pp. 2393–403. EBSCOhost, https://doi.org/10.1021/acs.bioconjchem.9b00510.

APA

Alain Faivre-Chauvet, Raphaël Tripier, Nathalie Le Bris, Thomas Le Bihan, Patricia Le Saëc, Mickaël Bourgeois, Clément Bailly, Catherine Saï-Maurel, Michel Chérel, & Anne-Sophie Navarro. (2019). TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model. Bioconjugate Chemistry, 30, 2393–2403. https://doi.org/10.1021/acs.bioconjchem.9b00510

Chicago

Alain Faivre-Chauvet, Raphaël Tripier, Nathalie Le Bris, Thomas Le Bihan, Patricia Le Saëc, Mickaël Bourgeois, Clément Bailly, Catherine Saï-Maurel, Michel Chérel, and Anne-Sophie Navarro. 2019. “TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 MAb in a Syngeneic Multiple Myeloma Model.” Bioconjugate Chemistry 30 (August): 2393–2403. doi:10.1021/acs.bioconjchem.9b00510.